BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15599404)

  • 41. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
    Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
    J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.
    Heldwein KA; Liang MD; Andresen TK; Thomas KE; Marty AM; Cuesta N; Vogel SN; Fenton MJ
    J Leukoc Biol; 2003 Aug; 74(2):277-86. PubMed ID: 12885945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.
    Chen M; Barnfield C; Näslund TI; Fleeton MN; Liljeström P
    J Virol; 2005 Mar; 79(5):2964-72. PubMed ID: 15709016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice.
    Akazawa T; Masuda H; Saeki Y; Matsumoto M; Takeda K; Tsujimura K; Kuzushima K; Takahashi T; Azuma I; Akira S; Toyoshima K; Seya T
    Cancer Res; 2004 Jan; 64(2):757-64. PubMed ID: 14744795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.
    Carranza C; Juárez E; Torres M; Ellner JJ; Sada E; Schwander SK
    Am J Respir Crit Care Med; 2006 Jan; 173(2):238-45. PubMed ID: 16210664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
    Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A
    J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infection.
    Ma C; Li Y; Li M; Deng G; Wu X; Zeng J; Hao X; Wang X; Liu J; Cho WC; Liu X; Wang Y
    Mol Immunol; 2014 Nov; 62(1):150-8. PubMed ID: 24995397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection.
    Weighardt H; Kaiser-Moore S; Vabulas RM; Kirschning CJ; Wagner H; Holzmann B
    J Immunol; 2002 Sep; 169(6):2823-7. PubMed ID: 12218091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.
    Goldstein DR; Tesar BM; Akira S; Lakkis FG
    J Clin Invest; 2003 May; 111(10):1571-8. PubMed ID: 12750407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates.
    Geisel RE; Sakamoto K; Russell DG; Rhoades ER
    J Immunol; 2005 Apr; 174(8):5007-15. PubMed ID: 15814731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent.
    Drennan MB; Stijlemans B; Van den Abbeele J; Quesniaux VJ; Barkhuizen M; Brombacher F; De Baetselier P; Ryffel B; Magez S
    J Immunol; 2005 Aug; 175(4):2501-9. PubMed ID: 16081822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MyD88 and interferon-alpha/beta are differentially required for dendritic cell maturation but dispensable for development of protective memory against Listeria.
    Tam MA; Wick MJ
    Immunology; 2009 Nov; 128(3):429-38. PubMed ID: 20067542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1.
    Mansur DS; Kroon EG; Nogueira ML; Arantes RM; Rodrigues SC; Akira S; Gazzinelli RT; Campos MA
    Am J Pathol; 2005 May; 166(5):1419-26. PubMed ID: 15855642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toll-dependent control mechanisms of CD4 T cell activation.
    Pasare C; Medzhitov R
    Immunity; 2004 Nov; 21(5):733-41. PubMed ID: 15539158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice.
    Patankar YR; Sutiwisesak R; Boyce S; Lai R; Lindestam Arlehamn CS; Sette A; Behar SM
    Mucosal Immunol; 2020 Jan; 13(1):140-148. PubMed ID: 31636345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Th1 immune response induced by Mycobacterium tuberculosis H37Ra in NOD2 knockout mice].
    Chen S; Zhang Q; Liu J; Tang Y; Han H; Liang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):577-582. PubMed ID: 31537240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice.
    Lee J; Brehm MA; Greiner D; Shultz LD; Kornfeld H
    BMC Immunol; 2013 Dec; 14():53. PubMed ID: 24313934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.
    Rogers KA; Rogers AB; Leav BA; Sanchez A; Vannier E; Uematsu S; Akira S; Golenbock D; Ward HD
    Infect Immun; 2006 Jan; 74(1):549-56. PubMed ID: 16369011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus.
    Skerrett SJ; Liggitt HD; Hajjar AM; Wilson CB
    J Immunol; 2004 Mar; 172(6):3377-81. PubMed ID: 15004134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TLR2 on CD4+ and CD8+ T cells promotes control of Mycobacterium tuberculosis infection.
    Reba SM; Li Q; Onwuzulike S; Nagy N; Fletcher S; Parker K; Shaw RJ; Umphred-Wilson K; Shukla S; Harding CV; Boom WH; Rojas RE
    Eur J Immunol; 2024 May; 54(5):e2350715. PubMed ID: 38446066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.